Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report.
Anemia
Liver
Metastasis
Paraganglioma
Transarterial chemoembolization
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
08 Aug 2019
08 Aug 2019
Historique:
received:
27
05
2019
accepted:
31
07
2019
entrez:
10
8
2019
pubmed:
10
8
2019
medline:
6
2
2020
Statut:
epublish
Résumé
Paragangliomas, also known as chemodectomas, are rare tumors arise from chemoreceptor tissue, and most commonly locate at the bifurcation of the common carotid, the jugular foramen, aortic arch, and retroperitoneum. Paragangliomas generally are considered to be benign tumors, and rarely produce local or distant metastases. Metastasis to liver is extremely rare. We report the case of a 39-year-old woman, who had undergone resection of a retroperitoneal paraganglioma at her local hospital for 12 years. She was referred to our hospital for further evaluation of a hepatic mass, which was misdignosed as hepatocellular carcinoma (HCC) and was treated by transarterial chemoembolization (TACE) in the local hospital 6 years ago. At admission, CT scan revealed a huge hypervascular mass with many feeding arteries, almost the same size as 5 years ago. Ultrasound-guided biopsy of the liver tumor was performed and immunohistochemical examination confirmed the diagnosis of hepatic metastatic paraganglioma. Though liver metastasis failed to achieve complete response or partial response to TACE treatment, it remained stable without progression during the 7-year follow-up. Paragangliomas are slow growing tumors and metastasis may develop decades after resection of the primary lesion. Long-term follow-up is necessary, and curative or palliative treatment should be considered to control symptoms, improve life quality, reduce complications and prolong survival.
Sections du résumé
BACKGROUND
BACKGROUND
Paragangliomas, also known as chemodectomas, are rare tumors arise from chemoreceptor tissue, and most commonly locate at the bifurcation of the common carotid, the jugular foramen, aortic arch, and retroperitoneum. Paragangliomas generally are considered to be benign tumors, and rarely produce local or distant metastases. Metastasis to liver is extremely rare.
CASE PRESENTATION
METHODS
We report the case of a 39-year-old woman, who had undergone resection of a retroperitoneal paraganglioma at her local hospital for 12 years. She was referred to our hospital for further evaluation of a hepatic mass, which was misdignosed as hepatocellular carcinoma (HCC) and was treated by transarterial chemoembolization (TACE) in the local hospital 6 years ago. At admission, CT scan revealed a huge hypervascular mass with many feeding arteries, almost the same size as 5 years ago. Ultrasound-guided biopsy of the liver tumor was performed and immunohistochemical examination confirmed the diagnosis of hepatic metastatic paraganglioma. Though liver metastasis failed to achieve complete response or partial response to TACE treatment, it remained stable without progression during the 7-year follow-up.
CONCLUSION
CONCLUSIONS
Paragangliomas are slow growing tumors and metastasis may develop decades after resection of the primary lesion. Long-term follow-up is necessary, and curative or palliative treatment should be considered to control symptoms, improve life quality, reduce complications and prolong survival.
Identifiants
pubmed: 31395026
doi: 10.1186/s12876-019-1061-6
pii: 10.1186/s12876-019-1061-6
pmc: PMC6688228
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
142Commentaires et corrections
Type : ErratumIn
Références
Cancer. 1992 Feb 1;69(3):790-2
pubmed: 1309681
Rev Esp Med Nucl. 2006 May-Jun;25(3):204-5
pubmed: 16762278
Skull Base Surg. 1995;5(2):83-91
pubmed: 17171181
Minn Med. 1976 Dec;59(12):844-8
pubmed: 187922
Neuroradiol J. 2013 Dec;26(6):678-82
pubmed: 24355187
G Chir. 2014 Jan-Feb;35(1-2):47-51
pubmed: 24690341
Surgery. 2017 Jan;161(1):220-227
pubmed: 27865588
Liver Int. 2018 Jun;38(6):1055-1063
pubmed: 29028279
Histopathology. 2018 Jan;72(1):97-105
pubmed: 29239044
Liver Int. 2018 Sep;38(9):1624-1634
pubmed: 29791968
Surgery. 2018 Sep;164(3):511-517
pubmed: 29929757
Cancer. 2019 Apr 15;125(8):1258-1266
pubmed: 30644531
Surgery. 2019 Apr;165(4):853-858
pubmed: 30686514
Neuroendocrinology. 2019 Mar 12;:null
pubmed: 30856620
Surgery. 2019 Jun 22;:null
pubmed: 31239074
Cancer. 1978 Dec;42(6):2865-9
pubmed: 365319
Br J Surg. 1986 Jan;73(1):14-6
pubmed: 3947866
J Natl Med Assoc. 1985 Sep;77(9):750, 755-6
pubmed: 4057278
Arch Otolaryngol. 1983 Apr;109(4):269-72
pubmed: 6299257
Acta Oncol. 1994;33(1):77-8
pubmed: 8142132
Rev Med Liege. 1997;52(7):485-97
pubmed: 9289786
J Chir (Paris). 1997 Dec;134(7-8):336-9
pubmed: 9773002